Omar T Atiq, MD

Research Program: Cancer Prevention and Population Sciences Faculty Rank: Professor Campus: University of Arkansas for Medical Sciences College: College of Medicine Department: Internal Med Hem-Onc

Cancer Research Interest

• Disease Site Focus: Head and Neck
• Research Focus Area: Treatment, Detection, Diagnosis/ Prognosis
• Type of Research: Clinical
• Research Interest Statement: Research interests include investigating the efficacy of therapeutic vaccines in an adjuvant setting to reduce the risk of recurrence in head and neck cancers, the role of gut microbiome in head and neck cancers, and strategies to improve effectiveness of noval therapies for head and neck and lung cancers while minimizing adverse effects of such interventions.

Contact Information

• Email Address: OTATIQ@UAMS.EDU
• Profiles Research Networking Software: View Profile

Open Clinical Trials

• “A Phase II Clinical Trial of Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence ” (NCT05952934)
• “NRG-HN009: Randomized Phase II/III Trial of Radiation with Cisplatin at 100mg/m2 Every Three Weeks Versus Radiation with Weekly Cisplatin at 40mg/m2 for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) ” (NCT05050162)
• “EA3191 A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab after Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features ” (NCT04671667)

Active Grants

• NIH/Nat. Cancer Institute – 2R01CA143130
  “Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal”
  Co-Investigator
  7/1/2021 – 6/30/2026

Recent Publications

• Tu SM, Trikannad AK, Vellanki S, [et al., including Atiq OT]. Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care. Cancers. 2024 16(6). PMID: 38539487. PMCID: PMC10969562.
• Dobrovolsky VN, Atiq OT, Heflich RH, [et al.]. Erythrocyte PIG-A mutant frequencies in cancer patients receiving cisplatin. Cancer medicine. 2024. PMID: 38214136. PMCID: PMC10905239.
• Serchen J, Mathew S, Hilden D, [et al., including Atiq O]. Supporting the Health and Well-Being of Indigenous Communities: A Position Paper From the American College of Physicians. Annals of internal medicine. 2022 175(11):1594-1597. PMID: 36215716.
• Serchen J, Atiq O, Hilden D. Strengthening Food and Nutrition Security to Promote Public Health in the United States: A Position Paper From the American College of Physicians. Annals of internal medicine. 2022 175(8):1170-1171. PMID: 35759767.
• Crowley R, Atiq O, Hilden D. Long-Term Services and Supports for Older Adults: A Position Paper From the American College of Physicians. Annals of internal medicine. 2022 175(8):1172-1174. PMID: 35816710.
• Tu SM, Singh SR, Arnaoutakis K, [et al., including Atiq OT]. Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench. Cancers. 2022 14(14). PMID: 35884406. PMCID: PMC9321703.
• Ma L, Peterson EA, Shin IJ, [et al., including Atiq O]. An advanced molecular medicine case report of a rare human tumor using genomics, pathomics, and radiomics. Frontiers in genetics. 2022 13:987175. PMID: 36846293. PMCID: PMC9951004.
• Crowley R, Atiq O, Hilden D, Cooney TG. Health Care for Our Nation's Veterans: A Policy Paper From the American College of Physicians. Annals of internal medicine. 2021. PMID: 34606323.
• Crowley R, Atiq O, Hilden D. Financial Profit in Medicine: A Position Paper From the American College of Physicians. Annals of internal medicine. 2021. PMID: 34487452.
• Atiq S, Atiq OO, Atiq ZO, [et al., including Atiq O]. A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy. Cureus. 2021 13(2):e13133. PMID: 33728149. PMCID: PMC7935157.
• Adkins D, Ley J, Atiq O, [et al.]. Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial. Oral oncology. 2021 115:105173. PMID: 33548860. PMCID: PMC8579485.
• Serchen J, Doherty R, Atiq O, Hilden D. A Comprehensive Policy Framework to Understand and Address Disparities and Discrimination in Health and Health Care: A Policy Paper From the American College of Physicians. Annals of internal medicine. 2021. PMID: 33428444.
• Serchen J, Doherty R, Atiq O, Hilden D. Racism and Health in the United States: A Policy Statement From the American College of Physicians. Annals of internal medicine. 2020 173(7):556-557. PMID: 32559145.
• Atiq O, Atiq SO, Atiq ZO, [et al., including Atiq O]. Pembrolizumab-Induced Cold Agglutinin Disease. The American journal of case reports. 2020 21:e924283. PMID: 32887867. PMCID: PMC7491957.